These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
698 related articles for article (PubMed ID: 28481733)
41. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447 [TBL] [Abstract][Full Text] [Related]
42. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme. Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557 [TBL] [Abstract][Full Text] [Related]
43. Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors. Yoon JH; Kim J; Kim KL; Kim DH; Jung SJ; Lee H; Ghim J; Kim D; Park JB; Ryu SH; Lee TG Proteomics; 2014 Jun; 14(12):1494-502. PubMed ID: 24729417 [TBL] [Abstract][Full Text] [Related]
44. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas]. Yu S; Pu P; Jiang D; An T; Guan X; Yang L Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884 [TBL] [Abstract][Full Text] [Related]
46. iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype. Rajcevic U; Petersen K; Knol JC; Loos M; Bougnaud S; Klychnikov O; Li KW; Pham TV; Wang J; Miletic H; Peng Z; Bjerkvig R; Jimenez CR; Niclou SP Mol Cell Proteomics; 2009 Nov; 8(11):2595-612. PubMed ID: 19674965 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas. Lin HH; Tsai WC; Tsai CK; Chen SH; Huang LC; Hueng DY; Hung KC J Mol Neurosci; 2021 Aug; 71(8):1614-1621. PubMed ID: 33641091 [TBL] [Abstract][Full Text] [Related]
48. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells]. Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625 [TBL] [Abstract][Full Text] [Related]
49. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947 [TBL] [Abstract][Full Text] [Related]
50. Deregulated expression of cry1 and cry2 in human gliomas. Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246 [TBL] [Abstract][Full Text] [Related]
51. Label-free quantitative proteomics unravels the importance of RNA processing in glioma malignancy. Bi B; Li F; Guo J; Li C; Jing R; Lv X; Chen X; Wang F; Azadzoi KM; Wang L; Liu Y; Yang JH Neuroscience; 2017 May; 351():84-95. PubMed ID: 28341197 [TBL] [Abstract][Full Text] [Related]
52. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas. Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031 [TBL] [Abstract][Full Text] [Related]
53. An integrated transcriptomic and computational analysis for biomarker identification in human glioma. Xing W; Zeng C Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173 [TBL] [Abstract][Full Text] [Related]
55. [Expression and significance of ABCG2 in human malignant glioma]. Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879 [TBL] [Abstract][Full Text] [Related]
56. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114 [TBL] [Abstract][Full Text] [Related]
57. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485 [TBL] [Abstract][Full Text] [Related]
58. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling. Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501 [TBL] [Abstract][Full Text] [Related]
59. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714 [TBL] [Abstract][Full Text] [Related]
60. Melatonergic system-based two-gene index is prognostic in human gliomas. Kinker GS; Oba-Shinjo SM; Carvalho-Sousa CE; Muxel SM; Marie SK; Markus RP; Fernandes PA J Pineal Res; 2016 Jan; 60(1):84-94. PubMed ID: 26510398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]